Growth Metrics

Cellebrite DI (CLBT) Shares Outstanding (Diluted Average) (2019 - 2025)

Cellebrite DI's Shares Outstanding (Diluted Average) history spans 7 years, with the latest figure at $249.9 million for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 19.3% to $249.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $249.9 million through Dec 2025, up 19.3% year-over-year, with the annual reading at $310.0 for FY2025, 100.0% down from the prior year.
  • Shares Outstanding (Diluted Average) came in at $249.9 million for Q4 2025, up from $230.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $249.9 million in Q4 2025 to a low of $20.0 in Q2 2021.
  • The 5-year median for Shares Outstanding (Diluted Average) is $405.0 (2022), against an average of $50.3 million.
  • Year-over-year, Shares Outstanding (Diluted Average) crashed 94.64% in 2023 and then soared 4900.0% in 2024.
  • Cellebrite DI's Shares Outstanding (Diluted Average) stood at $161.5 million in 2021, then grew by 20.96% to $195.4 million in 2022, then fell by 2.68% to $190.2 million in 2023, then increased by 10.16% to $209.5 million in 2024, then grew by 19.3% to $249.9 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Shares Outstanding (Diluted Average) are $249.9 million (Q4 2025), $230.0 (Q3 2025), and $150.0 (Q2 2025).